3D Bioprinting Biofabricating Skin Components

Instructor Image 3DHEALS
3D Bioprinting Biofabricating Skin Components

Join us for an extraordinary event delving into the cutting-edge realm of 3D Bioprinting and Biofabricating Skin Components. The hair follicle is an integral part of the skin that has functions beyond aesthetics. With leading experts in the field, this event promises to unravel the innovative techniques and transformative potential of bioprinting and biofabrication in revolutionizing skin regeneration and dermatology. From advancements in tissue engineering to the intricate process of bioprinting skin components, attendees will gain invaluable insights into the future of medical technology and the future of commercializing these technologies. Discover with the Tribe at the intersection of biology and technology as pioneers in this field showcase their groundbreaking research and real-world applications. Participants will explore this technology’s promising avenues for personalized medicine, cosmetic enhancement, and wound healing through engaging presentations, interactive demonstrations, and thought-provoking discussions. Don’t miss this opportunity to be at the forefront of scientific exploration and witness the remarkable strides made towards reshaping healthcare’s future through 3D bioprinting and biofabrication of skin components.


Dr. Pankaj Karande


Dr. Pankaj Karande is an Associate Professor in Chemical and Biological Engineering at Rensselaer Polytechnic Institute. He was awarded his B.S. in Chemical Engineering from Mumbai University Institute of Chemical Technology and his Ph.D. in Chemical Engineering from the University of California, Santa Barbara. Pankaj was awarded an Anna Fuller Postdoctoral Fellowship in Molecular Oncology, and he conducted postdoctoral research in the Center for Cancer Research at Massachusetts Institute of Technology before joining the faculty at Rensselaer. Pankaj has received a variety of awards and honors in his career, including the Excellence in Classroom Instruction Award and the Outstanding Teaching Award from Rensselaer Polytechnic Institute. He also received the Alzheimer’s Association New Investigator Research Award, the Goldhirsh Brain Tumor Research Award, and a Bronze Edison Award in the Best New Product in Science and Medical Category. In addition, he has been issued multiple patents in the areas of Transdermal Formulation Discovery and Novel High Throughput Screening Platforms.

Dr. Meghan Samberg

Meghan Samberg, PhD, is the Chief Development Officer at Stemson Therapeutics where she oversees the development of tissue engineered cell therapy products that are designed for the regeneration of new hair follicles for any type and stage of hair loss. She is experienced in growing seed stage companies within the fields of regenerative and translational medicine with specialties in skin wound healing, tissue engineering, animal model development and testing, nanoparticle toxicology, biomaterial fabrication, and lyophilization. Prior to joining Stemson, Meghan simultaneously served as the VP of Clinical Affairs at ISTO Biologics, an orthobiologics company, where she led all laboratory, preclinical, and clinical research efforts, and VP & GM of Compass Biomedical, a biologics company specializing in blood-based products and therapies. In addition to serving as the PI and PM on multi-million-dollar NIH, DoD, and BARDA funded preclinical and clinical programs for Compass products, she oversaw the CDMO services for seed stage companies, translating their R&D concepts into cGMP processes and serving as their regulatory contact. Meghan holds a BS in Biological Engineering from the University of Georgia, an MS in Biomedical Engineering from Yale University, and a PhD from The University of North Carolina at Chapel Hill and North Carolina State University. She conducted post-doctoral research at NCSU and at the United States Army Institute for Surgical Research at Fort Sam Houston.

Dr. Fabien Guillemot


Dr. Fabien GUILLEMOT is a scientist-turned-entrepreneur, CEO and Founder of Poietis, whose mission is to develop and market the Next-Gen Bioprinting platform to bring Tissue Engineering therapies to patients. Fabien has an over 25 years experience in the field of Biofabrication. He holds a PhD in Material Science (INSA, 2000) and an Habilitation in Health and Life Sciences (Bordeaux University, 2010). He was appointed Researcher at INSERM, France in 2005, and invited researcher at Harvard University in 2010. Bioprinting pioneer and inventor (with 100+ publications and 13 patents), he left for entrepreneurship via training at HEC-Paris and cofounded Poietis in 2014.

Dr. Ibrahim Tarik Ozbolat

Dr. Ozbolat is a Dorothy Foehr Huck and J. Lloyd Huck Chair in 3D Bioprinting and Regenerative Medicine and Professor of Engineering Science and Mechanics Department, Biomedical Engineering Department, and Neurosurgery Department at Penn State. Dr. Ozbolat’s major research thrust is in the area of Bioprinting. His research on bioprinting for tissue and organ fabrication has been published in several high-quality venues, received various awards and has been featured in national and international media, broadcast TVs and press numerous times. He frequently gives talks at national and international forums, conferences and seminars and organizes demonstrations and events to the public and youths to encourage participation of future’s engineers in medicine, engineering and science.


Dr. Jenny Chen

jenny chen

Dr. Jenny Chen is trained as a neuroradiologist, and founder/CEO of 3DHEALS. Her main interests include next-generation education, 3D printing in the healthcare sector, automated biology, and artificial intelligence. She is an angel investor who invests in Pitch3D companies.